PIPERACILLIN SODIUM,TAZOBACTAM SODIUM and DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS

Overview

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is the #10 most commonly reported adverse reaction for PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, manufactured by Fresenius Kabi USA, LLC. There are 865 FDA adverse event reports linking PIPERACILLIN SODIUM,TAZOBACTAM SODIUM to DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS. This represents approximately 1.9% of all 44,977 adverse event reports for this drug.

Patients taking PIPERACILLIN SODIUM,TAZOBACTAM SODIUM who experience drug reaction with eosinophilia and systemic symptoms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is a less commonly reported adverse event for PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, but still significant enough to appear in the safety profile.

Other Side Effects of PIPERACILLIN SODIUM,TAZOBACTAM SODIUM

In addition to drug reaction with eosinophilia and systemic symptoms, the following adverse reactions have been reported for PIPERACILLIN SODIUM,TAZOBACTAM SODIUM:

• DRUG INEFFECTIVE — 2,726 reports
• OFF LABEL USE — 2,486 reports
• ACUTE KIDNEY INJURY — 1,855 reports
• PYREXIA — 1,628 reports
• DIARRHOEA — 1,045 reports
• CONDITION AGGRAVATED — 1,012 reports
• THROMBOCYTOPENIA — 955 reports
• PNEUMONIA — 931 reports
• NEUTROPENIA — 909 reports
• FEBRILE NEUTROPENIA — 815 reports

Other Drugs Associated with DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS

The following drugs have also been linked to drug reaction with eosinophilia and systemic symptoms in FDA adverse event reports:

Does PIPERACILLIN SODIUM,TAZOBACTAM SODIUM cause DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS?

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS has been reported as an adverse event in 865 FDA reports for PIPERACILLIN SODIUM,TAZOBACTAM SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS with PIPERACILLIN SODIUM,TAZOBACTAM SODIUM?

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS accounts for approximately 1.9% of all adverse event reports for PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, making it a notable side effect.

What should I do if I experience DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS while taking PIPERACILLIN SODIUM,TAZOBACTAM SODIUM?

If you experience drug reaction with eosinophilia and systemic symptoms while taking PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages